A detailed history of Elevatus Welath Management transactions in Johnson & Johnson stock. As of the latest transaction made, Elevatus Welath Management holds 1,410 shares of JNJ stock, worth $223,273. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,410
Previous 1,418 0.56%
Holding current value
$223,273
Previous $224 Million 8.16%
% of portfolio
0.08%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $1,155 - $1,262
-8 Reduced 0.56%
1,410 $206 Million
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $776 - $813
5 Added 0.35%
1,418 $224 Million
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $56,638 - $61,804
-389 Reduced 21.59%
1,413 $222 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $63,234 - $70,838
406 Added 29.08%
1,802 $281 Million
Q2 2023

Aug 08, 2023

BUY
$154.35 - $166.11 $215,472 - $231,889
1,396 New
1,396 $231 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $414B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Elevatus Welath Management Portfolio

Follow Elevatus Welath Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elevatus Welath Management, based on Form 13F filings with the SEC.

News

Stay updated on Elevatus Welath Management with notifications on news.